Company intelligence / Profile preview
Max Zeller Söhne
Romanshorn, Thurgau, Switzerlandzellerag.ch ↗
- Ownership
- Private
- Employees
- ~145
- Development stage
- Other
01
Overview
Max Zeller Söhne is a Swiss market leader in clinically proven phytopharmaceuticals. The company controls the entire value chain from seed to finished product and has published preclinical and clinical studies supporting its products' efficacy. Its portfolio includes several well-established herbal medicines for women's health, CNS conditions, and allergies. Products are marketed in Switzerland and over 30 countries worldwide.
- Therapeutic areas
- ImmunologyNeurologyWomen's Health
- Modalities
- Herbal medicinePhytopharmaceuticals (plant-based medicines)Small molecule
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
Not specifically listed; collaborates with Vitaplant for raw materials.
Beyond the preview
Go deeper on Max Zeller Söhne.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Max Zeller Söhne.